- Record: found
- Abstract: not found
- Article: not found
Phase III FREEDOMS study extension: fingolimod (FTY720) efficacy in patients with relapsing-remitting multiple sclerosis receiving continuous or placebo-fingolimod switched therapy for up to 4 years
L Kappos, EW Radue, P O’Connor, R Gold, DH Miller, DG MacManus, E Havrdova, V Limmroth, CH Polman, K Schmierer, TA Yousry, M Eraksoy, E Meluzinova, M Dufek, M Yang, K Dawson, GN O’Neill
2012
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
Comments
Comment on this article
scite_